Alzheimer's Disease Therapeutics and Diagnostics Market Report – Research, Industry Analysis Reports and Market Demands

Global Alzheimer's Disease Therapeutics and Diagnostics Market Research Report 2019

Request for Sample of this report

Buy now

Table of Content

Executive Summary

1 Alzheimer's Disease Therapeutics and Diagnostics Market Overview

1.1 Product Overview and Scope of Alzheimer's Disease Therapeutics and Diagnostics
1.2 Alzheimer's Disease Therapeutics and Diagnostics Segment by Type
- 1.2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Biomarkers
- 1.2.3 Cholinesterase inhibitors
- 1.2.4 NMDA receptor antagonists
- 1.2.5 Brain imaging
- 1.2.6 Blood tests
1.3 Alzheimer's Disease Therapeutics and Diagnostics Segment by Application
- 1.3.1 Alzheimer's Disease Therapeutics and Diagnostics Consumption Comparison by Application (2014-2025)
- 1.3.2 Drugs Market
- 1.3.3 Diagnostics Market
1.4 Global Alzheimer's Disease Therapeutics and Diagnostics Market by Region
- 1.4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Alzheimer's Disease Therapeutics and Diagnostics Market Size
- 1.5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue (2014-2025)
- 1.5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Production (2014-2025)

2 Global Alzheimer's Disease Therapeutics and Diagnostics Market Competition by Manufacturers

2.1 Global Alzheimer's Disease Therapeutics and Diagnostics Production Market Share by Manufacturers (2014-2019)
2.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Share by Manufacturers (2014-2019)
2.3 Global Alzheimer's Disease Therapeutics and Diagnostics Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Alzheimer's Disease Therapeutics and Diagnostics Production Sites, Area Served, Product Types
2.5 Alzheimer's Disease Therapeutics and Diagnostics Market Competitive Situation and Trends
- 2.5.1 Alzheimer's Disease Therapeutics and Diagnostics Market Concentration Rate
- 2.5.2 Alzheimer's Disease Therapeutics and Diagnostics Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion

3 Global Alzheimer's Disease Therapeutics and Diagnostics Production Market Share by Regions

3.1 Global Alzheimer's Disease Therapeutics and Diagnostics Production Market Share by Regions
3.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Regions (2014-2019)
3.3 Global Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Alzheimer's Disease Therapeutics and Diagnostics Production
- 3.4.1 North America Alzheimer's Disease Therapeutics and Diagnostics Production Growth Rate (2014-2019)
- 3.4.2 North America Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Alzheimer's Disease Therapeutics and Diagnostics Production
- 3.5.1 Europe Alzheimer's Disease Therapeutics and Diagnostics Production Growth Rate (2014-2019)
- 3.5.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Alzheimer's Disease Therapeutics and Diagnostics Production (2014-2019)
- 3.6.1 China Alzheimer's Disease Therapeutics and Diagnostics Production Growth Rate (2014-2019)
- 3.6.2 China Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Alzheimer's Disease Therapeutics and Diagnostics Production (2014-2019)
- 3.7.1 Japan Alzheimer's Disease Therapeutics and Diagnostics Production Growth Rate (2014-2019)
- 3.7.2 Japan Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption by Regions

4.1 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption by Regions
4.2 North America Alzheimer's Disease Therapeutics and Diagnostics Consumption (2014-2019)
4.3 Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption (2014-2019)
4.4 China Alzheimer's Disease Therapeutics and Diagnostics Consumption (2014-2019)
4.5 Japan Alzheimer's Disease Therapeutics and Diagnostics Consumption (2014-2019)

5 Global Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue, Price Trend by Type

5.1 Global Alzheimer's Disease Therapeutics and Diagnostics Production Market Share by Type (2014-2019)
5.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue Market Share by Type (2014-2019)
5.3 Global Alzheimer's Disease Therapeutics and Diagnostics Price by Type (2014-2019)
5.4 Global Alzheimer's Disease Therapeutics and Diagnostics Production Growth by Type (2014-2019)

6 Global Alzheimer's Disease Therapeutics and Diagnostics Market Analysis by Applications

6.1 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Market Share by Application (2014-2019)
6.2 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Alzheimer's Disease Therapeutics and Diagnostics Business

8 Alzheimer's Disease Therapeutics and Diagnostics Manufacturing Cost Analysis

8.1 Alzheimer's Disease Therapeutics and Diagnostics Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Alzheimer's Disease Therapeutics and Diagnostics
8.4 Alzheimer's Disease Therapeutics and Diagnostics Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
9.2 Alzheimer's Disease Therapeutics and Diagnostics Distributors List
9.3 Alzheimer's Disease Therapeutics and Diagnostics Customers

10 Market Dynamics

10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Alzheimer's Disease Therapeutics and Diagnostics Market Forecast

11.1 Global Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue Forecast
- 11.1.1 Global Alzheimer's Disease Therapeutics and Diagnostics Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Alzheimer's Disease Therapeutics and Diagnostics Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Alzheimer's Disease Therapeutics and Diagnostics Price and Trend Forecast (2019-2025)
11.2 Global Alzheimer's Disease Therapeutics and Diagnostics Production Forecast by Regions (2019-2025)
- 11.2.1 North America Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue Forecast (2019-2025)
- 11.2.3 China Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue Forecast (2019-2025)
11.3 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2019-2025)
- 11.3.2 Europe Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2019-2025)
- 11.3.3 China Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2019-2025)
- 11.3.4 Japan Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast (2019-2025)
11.4 Global Alzheimer's Disease Therapeutics and Diagnostics Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Alzheimer's Disease Therapeutics and Diagnostics Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
13.3 Author List

Description

Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an exponential rise in the number of cases of Alzheimer’s disease worldwide emphasizing the necessity for developing an effective treatment. According to Alzheimer’s Association, in 2016, an estimated 5.4 million Americans of all ages have Alzheimer's disease. One in nine people aged 65 and above has Alzheimer's disease. By 2050, the number of people aged 65 and above affected with Alzheimer's disease is expected to nearly triple, from 5.2 million to an expected 13.8 million, excluding the development of medical advances to avert or cure the disease. The mortality rates due to Alzheimer’s disease are quite high. Between 2000 and 2013, deaths due to heart disease, stroke and prostate cancer decreased 14%, 23% and 11%, respectively, while deaths from AD increased 71% in the U.S. Similarly, According to Alzheimer’s disease International in 2015, there are an estimated 46.8 million people worldwide living with dementia and is further expected to grow in future. Thus, there is an increasing in the demand for Alzheimer’s therapeutics and diagnostics worldwide.

Population aging across the globe is a major factor driving the market for Alzheimer’s therapeutics and diagnostics. Rising life expectancy is contributing to quick increases in number of aged population, and is associated with increased prevalence of chronic diseases like dementia. Therapies for AD offer temporary and uncertain improvements in the well-being of individuals, and none of the approved drugs can modify the course of the disease advancement. Thus, the magnitude of the affected population and lack of suitable and effective treatment offers an incredible opportunity for drug manufacturers. However, identification of the primary reasons and mechanisms involved in AD are is limited. Drug manufacturers have been unable to validate significant clinical benefits of treatment for a numerous of new compounds due to strict regulations. One of the significant trend observed in this market is collaboration of the existing players. Precisely, diagnostic technology companies are carefully trying to bring about effective biomarker technologies to support and improve the drug development process for potential drug candidates which is further expected to propel the demand.

The global Alzheimer's Disease Therapeutics and Diagnostics market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Alzheimer's Disease Therapeutics and Diagnostics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alzheimer's Disease Therapeutics and Diagnostics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Namenda
Aricept
Exelon
Solanezumab
Gantenerumab
Verubecestat
Pfizer
Eisai
Actavis
Lundbeck
Daiichi Sankyo
Novartis
TauRx

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Biomarkers
Cholinesterase inhibitors
NMDA receptor antagonists
Brain imaging
Blood tests

Segment by Application
Drugs Market
Diagnostics Market